These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 33289904)

  • 1. Effective Pharmacovigilance System Development: EFPIA-IPVG Consensus Recommendations.
    Peters T; Soanes N; Abbas M; Ahmad J; Delumeau JC; Herrero-Martinez E; Paramananda M; Piper J; Smail-Aoudia F; van der Spuij W; Veizovic T; Winstanley G;
    Drug Saf; 2021 Jan; 44(1):17-28. PubMed ID: 33289904
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of a checklist for the assessment of pharmacovigilance guidelines in Southern Africa: a document review.
    Makhene NL; Steyn H; Vorster M; Lubbe MS; Burger JR
    Ther Adv Drug Saf; 2023; 14():20420986221143272. PubMed ID: 36713000
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An Industry Survey on Managing the Pharmacovigilance System Master File in a Global Environment: The Need for a Pragmatic Approach.
    Lavery C; Emmott J; Jeck-Thole S; Rouben P; Usher D; van der Spuij W; Woodward L
    Pharmaceut Med; 2022 Aug; 36(4):233-245. PubMed ID: 35723862
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fighting trafficking of falsified and substandard medicinal products in Russia.
    Fayzrakhmanov NF
    Int J Risk Saf Med; 2015; 27 Suppl 1():S37-40. PubMed ID: 26639702
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacovigilance in India, Uganda and South Africa with reference to WHO's minimum requirements.
    Maigetter K; Pollock AM; Kadam A; Ward K; Weiss MG
    Int J Health Policy Manag; 2015 Mar; 4(5):295-305. PubMed ID: 25905480
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CIOMS and ICH initiatives in pharmacovigilance and risk management: overview and implications.
    Tsintis P; La Mache E
    Drug Saf; 2004; 27(8):509-17. PubMed ID: 15154824
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Strengthening and rationalizing pharmacovigilance in the EU: where is Europe heading to? A review of the new EU legislation on pharmacovigilance.
    Borg JJ; Aislaitner G; Pirozynski M; Mifsud S
    Drug Saf; 2011 Mar; 34(3):187-97. PubMed ID: 21332243
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Funding and financial sustainability of pharmacovigilance: suggested models for funding pharmacovigilance in resource-limited African countries.
    Isah AO; Opadeyi AO; Tumwijukye H; Cobelens F; Smith D; Ndomondo-Sigonda M; Harmark L; Tanui P; Tiemersma E; Mmbaga BT; Mahlangu G; Ayinbuomwan SA; Soulaymani R; Pandit JM
    Ther Adv Drug Saf; 2023; 14():20420986231188836. PubMed ID: 37529763
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Issues with regulatory pharmacovigilance in East European countries: the industry perspective.
    Hanzl-Dujmović I; Sulić-Milisić Z; Staresinić-Sernhorst I
    Toxicol Lett; 2007 Feb; 168(3):228-35. PubMed ID: 17161561
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacovigilance: An Overview.
    Beninger P
    Clin Ther; 2018 Dec; 40(12):1991-2004. PubMed ID: 30126707
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Critical Care Network in the State of Qatar.
    Hijjeh M; Al Shaikh L; Alinier G; Selwood D; Malmstrom F; Hassan IF
    Qatar Med J; 2019; 2019(2):2. PubMed ID: 31763205
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhancing Pharmacovigilance in Sub-Saharan Africa Through Training and Mentoring: A GSK Pilot Initiative in Malawi.
    Jusot V; Chimimba F; Dzabala N; Menang O; Cole J; Gardiner G; Ofori-Anyinam O; Oladehin O; Sambakunsi C; Kawaye M; Stegmann JU; Guerra Mendoza Y
    Drug Saf; 2020 Jun; 43(6):583-593. PubMed ID: 32239447
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The 3T3 neutral red uptake phototoxicity test: practical experience and implications for phototoxicity testing--the report of an ECVAM-EFPIA workshop.
    Ceridono M; Tellner P; Bauer D; Barroso J; Alépée N; Corvi R; De Smedt A; Fellows MD; Gibbs NK; Heisler E; Jacobs A; Jirova D; Jones D; Kandárová H; Kasper P; Akunda JK; Krul C; Learn D; Liebsch M; Lynch AM; Muster W; Nakamura K; Nash JF; Pfannenbecker U; Phillips G; Robles C; Rogiers V; Van De Water F; Liminga UW; Vohr HW; Wattrelos O; Woods J; Zuang V; Kreysa J; Wilcox P
    Regul Toxicol Pharmacol; 2012 Aug; 63(3):480-8. PubMed ID: 22687423
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Enigma of Pharmacovigilance of Patient Support Programs: A Survey of Marketing Authorization Holders in Europe.
    Portnoff JM; Lewis DJ
    Ther Innov Regul Sci; 2017 Jul; 51(4):486-493. PubMed ID: 30227052
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Implementation of a Pharmacovigilance System in a Resources-Limited Country in the Context of COVID-19: Lebanon's Success Story.
    Abbas H; Zeitoun A; Watfa M; Karam R
    Ther Innov Regul Sci; 2023 Mar; 57(2):178-185. PubMed ID: 36109433
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacovigilance in Israel - tools, processes, and actions.
    Schwartzberg E; Berkovitch M; Dil Nahlieli D; Nathan J; Gorelik E
    Isr J Health Policy Res; 2017 Aug; 6(1):29. PubMed ID: 28760141
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of a pharmacovigilance system in a resource-limited country: the experience of the Democratic Republic of Congo.
    Nzolo D; Kuemmerle A; Lula Y; Ntamabyaliro N; Engo A; Mvete B; Liwono J; Lusakibanza M; Mesia G; Burri C; Mampunza S; Tona G
    Ther Adv Drug Saf; 2019; 10():2042098619864853. PubMed ID: 31360433
    [TBL] [Abstract][Full Text] [Related]  

  • 18. European pharmacovigilance: increasingly outsourced to drug companies.
    Prescrire Int; 2014 Dec; 23(155):302-3, 305-7. PubMed ID: 25629153
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Negotiating Your Way Through the Vigilance Agreement Maze-is There a Better Way?
    Corbel-Ecalard C; Kilgour-Christie J; Trun W; Lewis DJ
    Ther Innov Regul Sci; 2023 Sep; 57(5):1017-1029. PubMed ID: 37270450
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacovigilance in resource-limited countries.
    Olsson S; Pal SN; Dodoo A
    Expert Rev Clin Pharmacol; 2015; 8(4):449-60. PubMed ID: 26041035
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.